Phenprocoumon
| |
| Phenprocoumon
| |
| Systematic (IUPAC) name | |
| 2-hydroxy-3-(1-phenylpropyl)chromen-4-one | |
| Identifiers | |
| CAS number | |
| ATC code | B01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C18H16O3 |
| Mol. mass | 280.318 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 99% |
| Metabolism | hepatic to inactive metabolites |
| Half life | 5 to 6 days |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
|
WikiDoc Resources for Phenprocoumon | |
|
Articles | |
|---|---|
|
Most recent articles on Phenprocoumon Most cited articles on Phenprocoumon | |
|
Media | |
|
Powerpoint slides on Phenprocoumon | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Phenprocoumon at Clinical Trials.gov Trial results on Phenprocoumon Clinical Trials on Phenprocoumon at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Phenprocoumon NICE Guidance on Phenprocoumon
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Phenprocoumon Discussion groups on Phenprocoumon Patient Handouts on Phenprocoumon Directions to Hospitals Treating Phenprocoumon Risk calculators and risk factors for Phenprocoumon
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Phenprocoumon | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Phenprocoumon is an anticoagulant, functioning as a Vitamin K antagonist. It is a derivative of coumarin and is also marketed under the brand name Marcoumar. It is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders.
It is marketed as Marcoumar by Roche.
External links
WikiDoc Research Resources for Phenprocoumon | |
|---|---|
| Articles on Phenprocoumon | Most recent articles on Phenprocoumon • Most cited articles on Phenprocoumon • Review articles on Phenprocoumon • Articles on Phenprocoumon in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Phenprocoumon | Powerpoint slides on Phenprocoumon • Images of Phenprocoumon • Photos of Phenprocoumon • Podcasts & MP3s on Phenprocoumon • Videos on Phenprocoumon |
| Evidence Based Medicine Regarding Phenprocoumon | AND (Cochrane Database Syst Rev[http://worldselectshop.com/?id=9361 Cochrane Collaboration on Phenprocoumon • Bandolier on Phenprocoumon • TRIP on Phenprocoumon |
| Cost Effectiveness of Phenprocoumon | AND (Cost effectiveness) |
| group5 = Clinical Trials Involving Phenprocoumon | list5 = Ongoing Trials on Phenprocoumon at Clinical Trials.gov • Trial results on Phenprocoumon • Clinical Trials on Phenprocoumon at Google
| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Phenprocoumon
| list6 = US National Guidelines Clearinghouse on Phenprocoumon • NICE Guidance on Phenprocoumon • NHS PRODIGY Guidance • FDA on Phenprocoumon • CDC on Phenprocoumon
| group7 = Textbook Information on Phenprocoumon
| list7 = Books and Textbook Information on Phenprocoumon
| group8 = Pharmacology Resources on Phenprocoumon
| list8 =
AND (Dose)}} Dosing of Phenprocoumon • AND (drug interactions)}} Drug interactions with Phenprocoumon • AND (side effects)}} Side effects of Phenprocoumon • AND (Allergy)}} Allergic reactions to Phenprocoumon • AND (overdose)}} Overdose information on Phenprocoumon • AND (carcinogenicity)}} Carcinogenicity information on Phenprocoumon • AND (pregnancy)}} Phenprocoumon in pregnancy • AND (pharmacokinetics)}} Pharmacokinetics of Phenprocoumon •
| group9 = Genetics, Pharmacogenomics, and Proteinomics of Phenprocoumon
| list9 =
AND (pharmacogenomics)}} Genetics of Phenprocoumon • AND (pharmacogenomics)}} Pharmacogenomics of Phenprocoumon • AND (proteomics)}} Proteomics of Phenprocoumon
| group10 = Newstories on Phenprocoumon
| list10 = Phenprocoumon in the news • Be alerted to news on Phenprocoumon • News trends on Phenprocoumon</small>
| group11 = Commentary on Phenprocoumon
| list11 =
Blogs on Phenprocoumon
| group12 = Patient Resources on Phenprocoumon | list12 = Patient resources on Phenprocoumon • Discussion groups on Phenprocoumon • Patient Handouts on Phenprocoumon • Directions to Hospitals Treating Phenprocoumon • Risk calculators and risk factors for Phenprocoumon
| group13 = Healthcare Provider Resources on Phenprocoumon
| list13 =
Symptoms of Phenprocoumon • Causes & Risk Factors for Phenprocoumon • Diagnostic studies for Phenprocoumon • Treatment of Phenprocoumon
| group14 = Continuing Medical Education (CME) Programs on Phenprocoumon | list14 = CME Programs on Phenprocoumon
| group15 = International Resources on Phenprocoumon | list15 = Phenprocoumon en Espanol • Phenprocoumon en Francais
| group16 = Business Resources on Phenprocoumon | list16 = Phenprocoumon in the Marketplace • Patents on Phenprocoumon
| group17 = Informatics Resources on Phenprocoumon | list17 = List of terms related to Phenprocoumon
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
